EUVIMEDEUVIMED entdecken
Open Access

GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder

Kevin P Kennedy, Ryan Bremseth-Vining, Kevin G Lynch, Nicholas Reville, Jonathan Zhang, Jasmin Moshfegh, David W Oslin

The Journal of Clinical Psychiatry · 15.07.2026 · 87 (3)

DOI: 10.4088/jcp.25m16212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 15.07.2026. Verfasst von Kevin P Kennedy und 6 weiteren Autor:innen. Beteiligte Einrichtung: VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Veterans, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2VeteransGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsDrug OverdoseOpioid-Related DisordersGlucagon-Like PeptidesHumansSemaglutideTirzepatideMaleFemaleMiddle AgedUnited StatesMetforminInsulinDipeptidyl-Peptidase IV Inhibitors

Substanzen

SemaglutideTirzepatideGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsGlucagon-Like PeptidesMetforminInsulinDipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
  • Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Corresponding Author: Kevin P. Kennedy, MD, 3900 Woodland Ave #B228, Philadelphia, PA 19104 (kevin.kennedy2@va.gov).
  • Center for Addiction Science, Policy, and Research (CASPR), San Francisco, California.
  • Sanford School of Public Policy, Duke University, Durham, North Carolina.
  • US Department of Veterans Affairs Office of Mental Health, Washington D.C.

Förderung

  • Intramural VA

Zitieren

APA

Kennedy, K. P., Bremseth-Vining, R., Lynch, K. G., Reville, N., Zhang, J., Moshfegh, J., & Oslin, D. W. (2026). GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder. The Journal of Clinical Psychiatry, 87(3). https://doi.org/10.4088/jcp.25m16212

Vancouver

Kennedy KP, Bremseth-Vining R, Lynch KG, Reville N, Zhang J, Moshfegh J, et al. GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder. The Journal of Clinical Psychiatry. 2026;87(3). doi:10.4088/jcp.25m16212

BibTeX
@article{Kennedy2026,
  author = {Kennedy, Kevin P and Bremseth-Vining, Ryan and Lynch, Kevin G and Reville, Nicholas and Zhang, Jonathan and Moshfegh, Jasmin and Oslin, David W},
  title = {GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder},
  journal = {The Journal of Clinical Psychiatry},
  year = {2026},
  volume = {87},
  number = {3},
  doi = {10.4088/jcp.25m16212}
}
Kostenlos starten →